Top Story

Survey suggests partisanship doomed health care reform, public split on many ACA components

August 16, 2017

A greater Republican division on the issue of health care reform than originally thought in addition to the Democrats’ determination to not repeal the Affordable Care Act, led to the failure of health care reform efforts thus far, according to a special report recently published in The New England Journal of Medicine.

“Fundamental divisions among Republicans point to an underlying reason why Republicans in Congress had such difficulty agreeing on a single repeal and replace plan. These divisions were not helped by the fact that President Donald Trump’s role in the debate was seen so poorly by the general public,” Robert J. Blendon, ScD, and John M. Benson, MA, of the Harvard T.H. Chan School of Public Health, wrote.

Clinical trial stirs controversy over power morcellator bags

August 16, 2017
A clinical trial scheduled to evaluate the safety and efficacy of a bag designed to catch cancerous tissue from power morcellation in women undergoing laparoscopic…
FDA News

FDA grants priority review to Adcetris for cutaneous T-cell lymphoma

August 16, 2017
The FDA granted priority review to brentuximab vedotin for the treatment of cutaneous T-cell lymphoma, according to the drug’s manufacturer. The agency set a…

Nivolumab-ipilimumab combination improves response rate in renal cell carcinoma

August 16, 2017
A phase 3 trial designed to compare nivolumab plus ipilimumab with sunitinib monotherapy for first-line treatment of intermediate- or poor-risk patients with renal cell…

Kids First Data Resource Center set to ‘unlock potential’ of genomic data in pediatric cancer

August 16, 2017
The NIH established the Kids First Data Resource Center, a pediatric cancer and rare disease data program that will enable clinicians and researchers to collaborate and…
More Headlines »

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Meeting News

VIDEO: LATITUDE, STAMPEDE trials provide ‘practice-changing’ findings in prostate cancer

July 15, 2017
More »
Resource Centers


Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges

Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging…
More »
Current Issues
View the Current Issue
HemOnc Today